These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 28884634)

  • 1. The context and quality of evidence used by tobacco interests to oppose ANVISA's 2012 regulations in Brazil.
    Lencucha R; de Lima Pontes C
    Glob Public Health; 2018 Sep; 13(9):1204-1215. PubMed ID: 28884634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Governance and pharmacovigilance in Brazil: a scoping review.
    Moscou K; Kohler JC; MaGahan A
    J Pharm Policy Pract; 2016; 9():3. PubMed ID: 26862438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [History of Brazil's tobacco control policy from 1986 to 2016].
    Portes LH; Machado CV; Turci SRB
    Cad Saude Publica; 2018 Feb; 34(2):e00017317. PubMed ID: 29489940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The decision-making process in Brazil's ratification of the World Health Organization Framework Convention on Tobacco Control.
    Rangel EC; Pereira A; Cavalcante TM; Oliveira EA; Silva VLDCE
    Cad Saude Publica; 2017 Sep; 33Suppl 3(Suppl 3):e00126115. PubMed ID: 28954054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The creation of industry front groups: the tobacco industry and "get government off our back".
    Apollonio DE; Bero LA
    Am J Public Health; 2007 Mar; 97(3):419-27. PubMed ID: 17267719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hiding in the Shadows: Philip Morris and the Use of Third Parties to Oppose Ingredient Disclosure Regulations.
    Velicer C; Glantz SA
    PLoS One; 2015; 10(12):e0142032. PubMed ID: 26717245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Policy makers' perspectives on tobacco control advocates' roles in regulation development.
    Montini T; Bero LA
    Tob Control; 2001 Sep; 10(3):218-24. PubMed ID: 11544384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tobacco industry's use of Wall Street analysts in shaping policy.
    Alamar BC; Glantz SA
    Tob Control; 2004 Sep; 13(3):223-7. PubMed ID: 15333876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobacco industry tactics for resisting public policy on health.
    Saloojee Y; Dagli E
    Bull World Health Organ; 2000; 78(7):902-10. PubMed ID: 10994263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Brazilian National Health Surveillance Agency performance evaluation at the management contract model].
    Moreira EM; Costa EA
    Cien Saude Colet; 2010 Nov; 15 Suppl 3():3381-91. PubMed ID: 21120326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social participation in Anvisa's regulations: hybrid, colloquial, and scientific evidence for democratic decision-making.
    Caldeira TR; Mendonça AVM
    Cien Saude Colet; 2024 Jul; 29(7):e03172024. PubMed ID: 38958319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the tobacco industry's interference in the enforcement of health warnings on tobacco products in Brazil.
    Perez CA; Silva VLDCE; Bialous SA
    Cad Saude Publica; 2017 Oct; 33Suppl 3(Suppl 3):e00120715. PubMed ID: 29069212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tobacco Control Policies in Brazil: a 30-year assessment.
    Portes LH; Machado CV; Turci SRB; Figueiredo VC; Cavalcante TM; Silva VLDCE
    Cien Saude Colet; 2018 Jun; 23(6):1837-1848. PubMed ID: 29972492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Old wine in new bottles: tobacco industry's submission to European Commission tobacco product directive public consultation.
    Hiilamo H; Glantz SA
    Health Policy; 2015 Jan; 119(1):57-65. PubMed ID: 25467283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the logic and framing of a tobacco industry campaign opposing standardised packaging legislation in New Zealand.
    Waa AM; Hoek J; Edwards R; Maclaurin J
    Tob Control; 2017 Nov; 26(6):629-633. PubMed ID: 27694401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of the tobacco industry documents for public health and policy.
    Bero L
    Annu Rev Public Health; 2003; 24():267-88. PubMed ID: 12415145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Institutions and the implementation of tobacco control in Brazil.
    Lencucha R; Drope J; Bialous SA; Richter AP; Silva VLDCE
    Cad Saude Publica; 2017 Oct; 33Suppl 3(Suppl 3):e00168315. PubMed ID: 29069213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The power of a frame: an analysis of newspaper coverage of tobacco issues--United States, 1985-1996.
    Menashe CL; Siegel M
    J Health Commun; 1998; 3(4):307-25. PubMed ID: 10977260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Playing hide-and-seek with the tobacco industry.
    LeGresley EM; Muggli ME; Hurt RD
    Nicotine Tob Res; 2005 Feb; 7(1):27-40. PubMed ID: 15804675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Framing the nicotine debate: a cultural approach to risk.
    Murphy P
    Health Commun; 2001; 13(2):119-40. PubMed ID: 11451101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.